This section and the included press releases are presented for historical purposes only. Press releases and other documents speak only as of the date thereof.
Strong Investor Demand Increases Total Investments to $46M WESTLAKE VILLAGE, Calif.--( BUSINESS WIRE )-- Sienna Biopharmaceuticals, Inc. (Sienna), a clinical stage company focused on medical dermatology and aesthetics, today announced it has completed a second closing of its Series A financing,
Company Founded to Improve Patient Outcomes and Advance Practice of Medicine in Aesthetics and Medical Dermatology WESTLAKE VILLAGE, Calif.--( BUSINESS WIRE )--Sienna Biopharmaceuticals, Inc., a development stage company focused on aesthetics and medical dermatology, today announced that it